BK Virus in Recipients of Kidney Transplants

BK Virus in Recipients of Kidney Transplants

Identification: nnj_nd14A6
Issue: November-December 2014
Volume: Vol. 41, No. 6
Credits (Post Test and/or Evaluation Required)
Available until 12/31/2016
  • 1.40 - CH
  • 0.00 - Rx

Standard: $30.00

Description

Contact hours available until 12/31/2016.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Authors Conflict of Interest Disclosure:
The authors reported no actual or potential conflict of interest in relation to this continuing nursing education activity.

Nephrology Nursing Journal Editorial Board Statements of Disclosure

In accordance with ANCC governing rules Nephrology Nursing Journal Editorial Board statements of disclosure are published with each CNE offering. The statements of disclosure for this offering are published below.

Paula Dutka MSN, RN, CNN, disclosed that she is a coordinator of Clinical Trials for the following sponsors: Amgen, Rockwell Medical, Keryx Biopharmaceuticals, Akebia Therapeutics, and Dynavax Technologies.

Carol M. Headley DNSc, ACNP-BC, RN, CNN, disclosed that she is a Consultant and/or member of the Corporate Speaker’s Bureau for Sanofi Renal, and a member of the Advisory Board for Amgen.

Tamara M. Kear, PhD, RN, CNS, CNN, disclosed that she is a Fresenius employee, freelance editor for Lippincott Williams & Wilkins and Elsevier publishing companies, and a consultant for Symplmed.

All other members of the Editorial Board had no actual or potential conflict of interest in relation to this continuing nursing education activity.

This article was reviewed and formatted for contact hour credit by Beth Ulrich, EdD, RN, FACHE, FAAN, Nephrology Nursing Journal Editor, and Hazel A. Dennison, DNP, RN, APNc, CPHQ, CNE, ANNA Education Director.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Goal
To provide an overview of BK virus in kidney transplant recipients and its treatment.

Objectives:

  1. Discuss the epidemiology, structure, life cycle, transmission, and reactivation of the BK virus.
  2. Identify the risk factors for BK virus in kidney transplant recipients.
  3. Discuss the screening for and treatment of BK virus in kidney transplant recipients.

Author(s)

Credits Available


You must be logged in and own this product in order to post comments.